Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction-Reference-Cited by-同舟云学术

Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction

Published:2023-03-08 Issue:7 Volume:62 Page:1321-1329
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Jones Matthew¹,Grosche Philipp²,Floersheimer Andreas²,André Jérome²,Gattlen Raphael²,Oser Dieter²,Tinchant Juliette²,Wille Roman²,Chie-Leon Barbara³,Gerspacher Marc²,Ertl Peter²^ORCID,Ostermann Nils³^ORCID,Altmann Eva²^ORCID,Manchado Eusebio¹,Vorherr Thomas²,Chène Patrick¹^ORCID

Affiliation:

1. Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland

2. Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland

3. Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Emeryville, California 94608, United States

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biochem.2c00690

Reference43 articles.

1. Protein Lysine Acetylation by p300/CBP

2. The p300/CBP family: integrating signals with transcription factors and chromatin

3. Acetylation of Histones and Transcription-Related Factors

4. Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease

5. Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-throughput affinity measurements of direct interactions between activation domains and co-activators;2024-08-20

2. Transcription Factor MYB as Therapeutic Target: Current Developments;International Journal of Molecular Sciences;2024-03-12

3. Dynamics and interactions of intrinsically disordered proteins;Current Opinion in Structural Biology;2024-02

4. MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML;Advances in Experimental Medicine and Biology;2024

5. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand;Biochemistry;2023-12-12